Ultrasound (US) is a very helpful clinical tool in rheumatology due to its low cost, portability, and accessibility for point ...
A 65-year-old white woman presented with 9 months of intermittent “kaleidoscopic” visual disturbances and blurred vision upon ...
Pharmaceutical Technology on MSN
Novartis wins FDA approval for Cosentyx to treat paediatric HS patients
Cosentyx’s IL-17A mechanism provides a differentiated approach for HS in younger patients.
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Feb 17, 2026 at 8:25 ...
Feb 17 (Reuters) - Software startup Temporal has raised $300 million in a funding round led by Andreessen Horowitz, valuing the company at $5 billion, as demand rises for infrastructure to support ...
Add Yahoo as a preferred source to see more of our stories on Google. Feb 17 (Reuters) - Software startup Temporal has raised $300 million in a funding round led by Andreessen Horowitz, valuing the ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Ludi Akue discusses how the tech sector’s ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Venture heavyweight Andreessen ...
Paracentral acute middle maculopathy is a highly specific OCT marker for biopsy-proven giant cell arteritis with ocular ischemic involvement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results